Cargando…
Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment
In recent years, researchers have focused on targeted gene therapy for lung cancer, using nanoparticle carriers to overcome the limitations of conventional treatment methods. The main goal of targeted gene therapy is to develop more efficient therapeutic strategies by improving the bioavailability,...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480422/ https://www.ncbi.nlm.nih.gov/pubmed/28290155 http://dx.doi.org/10.1007/s41061-017-0128-5 |
_version_ | 1783245290072965120 |
---|---|
author | Amreddy, Narsireddy Babu, Anish Muralidharan, Ranganayaki Munshi, Anupama Ramesh, Rajagopal |
author_facet | Amreddy, Narsireddy Babu, Anish Muralidharan, Ranganayaki Munshi, Anupama Ramesh, Rajagopal |
author_sort | Amreddy, Narsireddy |
collection | PubMed |
description | In recent years, researchers have focused on targeted gene therapy for lung cancer, using nanoparticle carriers to overcome the limitations of conventional treatment methods. The main goal of targeted gene therapy is to develop more efficient therapeutic strategies by improving the bioavailability, stability, and target specificity of gene therapeutics and to reduce off-target effects. Polymer-based nanoparticles, an alternative to lipid and inorganic nanoparticles, efficiently carry nucleic acid therapeutics and are stable in vivo. Receptor-targeted delivery is a promising approach that can limit non-specific gene delivery and can be achieved by modifying the polymer nanoparticle surface with specific receptor ligands or antibodies. This review highlights the recent developments in gene delivery using synthetic and natural polymer-based nucleic acid carriers for lung cancer treatment. Various nanoparticle systems based on polymers and polymer combinations are discussed. Further, examples of targeting ligands or moieties used in targeted, polymer-based gene delivery to lung cancer are reviewed. |
format | Online Article Text |
id | pubmed-5480422 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-54804222017-07-07 Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment Amreddy, Narsireddy Babu, Anish Muralidharan, Ranganayaki Munshi, Anupama Ramesh, Rajagopal Top Curr Chem (J) Review In recent years, researchers have focused on targeted gene therapy for lung cancer, using nanoparticle carriers to overcome the limitations of conventional treatment methods. The main goal of targeted gene therapy is to develop more efficient therapeutic strategies by improving the bioavailability, stability, and target specificity of gene therapeutics and to reduce off-target effects. Polymer-based nanoparticles, an alternative to lipid and inorganic nanoparticles, efficiently carry nucleic acid therapeutics and are stable in vivo. Receptor-targeted delivery is a promising approach that can limit non-specific gene delivery and can be achieved by modifying the polymer nanoparticle surface with specific receptor ligands or antibodies. This review highlights the recent developments in gene delivery using synthetic and natural polymer-based nucleic acid carriers for lung cancer treatment. Various nanoparticle systems based on polymers and polymer combinations are discussed. Further, examples of targeting ligands or moieties used in targeted, polymer-based gene delivery to lung cancer are reviewed. Springer International Publishing 2017-03-13 2017 /pmc/articles/PMC5480422/ /pubmed/28290155 http://dx.doi.org/10.1007/s41061-017-0128-5 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review Amreddy, Narsireddy Babu, Anish Muralidharan, Ranganayaki Munshi, Anupama Ramesh, Rajagopal Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment |
title | Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment |
title_full | Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment |
title_fullStr | Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment |
title_full_unstemmed | Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment |
title_short | Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment |
title_sort | polymeric nanoparticle-mediated gene delivery for lung cancer treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5480422/ https://www.ncbi.nlm.nih.gov/pubmed/28290155 http://dx.doi.org/10.1007/s41061-017-0128-5 |
work_keys_str_mv | AT amreddynarsireddy polymericnanoparticlemediatedgenedeliveryforlungcancertreatment AT babuanish polymericnanoparticlemediatedgenedeliveryforlungcancertreatment AT muralidharanranganayaki polymericnanoparticlemediatedgenedeliveryforlungcancertreatment AT munshianupama polymericnanoparticlemediatedgenedeliveryforlungcancertreatment AT rameshrajagopal polymericnanoparticlemediatedgenedeliveryforlungcancertreatment |